EOC317
EOC317 (ACTB-1003) is an orally bioavailable small molecule inhibitor targeting FGFR1, VEGFR2, and Tie-2 kinases with IC50 values of 6, 2, and 4 nM, respectively. It is utilized in preclinical research to investigate angiogenesis and tumor growth in both cellular assays and animal models.
Product Specifications
CAS Number
939805-30-8
Product Name Alternative
ACTB 1003, ACTB1003, ACTB-1003, EOC 317, EOC317, EOC-317, Fibroblast growth factor receptor, FGFR, FGFR1, Inhibitor, inhibit, VEGFR2, VEGFR, Vascular endothelial growth factor receptor, Tie2, Tie-2
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (4.23 mM) ; DMSO:55 mg/mL (92.98 mM)
Smiles
COCc1c (CN2CCOCC2) n2ncnc (N) c2c1-c1ccc (NC (=O) Nc2cc (ccc2F) C (F) (F) F) c (F) c1
Molecular Formula
C27H26F5N7O3
Molecular Weight
591.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
EKL62620 96 Tests
Human RAB7A, Member RAS Oncogene Family (RAB7A) ELISA Kit
Sign In for Pricing
View Details 
